Trends in discontinuation by indication Side effects were consistently the top reason for stopping treatment for patients receiving ADM and AOM GLP-1s
Role of endogenous incretin hormones, GLP-1 and GIP, in cardiovascular physiology
To prevent misdiagnosing a child with RLS, we conduct a sleep study where we monitor for leg movements, says Avidan
Despite the effectiveness of the newer generation of anti-obesity drugs called GLP-1 receptor agonists few can tolerate them in the long run
Our goal is to give you the tools you need to achieve results that are not only effective, but sustainable and truly healthy."
This makes it relevant for laboratory investigations focused on metabolic network behavior, biomarker tracking, and systems-level endocrine responses [1][3][5]